• Home
  • Team
  • Product
  • News
  • Contact
shifabiomedical.com
  • Home
  • Team
  • Product
  • News
  • Contact

News

PRESS RELEASE

May 12, 2021
Shifa Launches with Seed Financing to Address Cardiovascular Disease by Developing Orally Bioavailable Drugs for the Treatment of Dyslipidemia - PharmiWeb.com

November 12, 2018
Shifa Biomedical Corporation Presents Preclinical Data on P-21, a Novel Orally Active PSCK9 Antagonist, at the American Heart Association (AHA) Meeting, Scientific Sessions 2018
Site powered by Weebly. Managed by pair Domains
  • Home
  • Team
  • Product
  • News
  • Contact